الكيميائية
2230TASIالرعاية الصحية
7.06ريال(0.11) (1.53%)
- افتتاح
- 7.19
- أعلى
- 7.20
- أدنى
- 7.05
- إغلاق سابق
- 7.17
- الكمية
- 1.08 مليون
- القيمة
- 7.67 مليون
- الصفقات
- 1,013
2230TASIالرعاية الصحية
(Revenue FY − Revenue FY-1) ÷ |Revenue FY-1|
(Net income FY − Net income FY-1) ÷ |Net income FY-1|
(Revenue FY ÷ Revenue FY-3)^(1/3) − 1; requires positive values
(Revenue FY ÷ Revenue FY-5)^(1/5) − 1; requires positive values
(Net income FY ÷ Net income FY-3)^(1/3) − 1; requires positive values
(Net income FY ÷ Net income FY-5)^(1/5) − 1; requires positive values
(EPS FY ÷ EPS FY-3)^(1/3) − 1; requires reported EPS per year
(EPS FY ÷ EPS FY-5)^(1/5) − 1; requires reported EPS per year
Gross profit FY ÷ Revenue FY
Operating income FY ÷ Revenue FY
Net income FY ÷ Revenue FY
Price × shares outstanding
Price ÷ EPS (TTM EPS when reported, else net income FY ÷ shares); null when EPS ≤ 0
Price ÷ (shareholders’ equity FY ÷ shares); null when equity ≤ 0
(Market cap + total debt − cash) ÷ EBITDA FY; requires cash and EBITDA
Dividends per share over the last 12 months (by eligibility date) ÷ price
Dividends per share (12 months) ÷ EPS
Current assets ÷ current liabilities; requires current balances
Total debt FY ÷ shareholders’ equity FY
Total liabilities FY ÷ total assets FY
(Total debt − cash) ÷ EBITDA FY; requires cash and EBITDA
Revenue FY ÷ average total assets (FY, FY-1)
Operating cash flow FY ÷ net income FY; null when net income ≤ 0
Net income FY ÷ average shareholders’ equity (FY, FY-1); null when closing equity ≤ 0
Net income FY ÷ average total assets (FY, FY-1)
Operating income × (1 − effective tax rate) ÷ (total debt + equity); requires tax data
Free cash flow FY ÷ market cap
Operating income FY ÷ interest expense FY; requires interest expense